Publications by authors named "Manuel DaFonseca"

Claim this Profile
A
A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers.
Richard T Kenney, John K Cini, Susan Dexter, Manuel DaFonseca, Justus Bingham

Front Immunolยท March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis